Paper23878286
Recurrent glioblastoma: optimum area under the curve method derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging.
Chung WJ and 4 others. Radiology, 2013. Cited by 77 papers, by iCite.
Cite this record
ConductScience Library. Recurrent glioblastoma: optimum area under the curve method derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging. Papers, record 23878286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23878286
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recurrent glioblastoma: optimum area under the curve method derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glioblastoma | Major topic |
| Magnetic Resonance Imaging | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Adult | |
| Aged | |
| Area Under Curve | |
| Contrast Media | |
| Diagnosis, Differential | |
| Female | |
| Humans | |
| Image Interpretation, Computer-Assisted | |
| Male | |
| Middle Aged | |
| Radiation Injuries | |
| Retrospective Studies |
Source PubMed
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42128847 | A Novel MR Cine Sialography Technique for Evaluating Salivary Gland Function: Correlation with Unstimulated and Stimulated Saliva Volumes. | Magn Reson Med Sci | 2026 | https://conductscience.org/library/papers/42128847 | PubMed |
| 41621439 | Dynamic Contrast Enhanced-Magnetic Resonance Fingerprinting (DCE-MRF) Improves Detection of Induced Vascular Perfusion Reduction in a Mouse Breast Cancer Model. | Magn Reson Med | 2026 | https://conductscience.org/library/papers/41621439 | PubMed |
| 41489694 | Time-dependent diffusion-weighted imaging assessment of tumor grading and isocitrate dehydrogenase genotypes in adult-type diffuse gliomas. | Jpn J Radiol | 2026 | https://conductscience.org/library/papers/41489694 | PubMed |
| 40785853 | Whole-tumor histogram analysis of synthetic MRI for discriminating benign from malignant sinonasal tumors: correlations with histopathologic factors. | Quant Imaging Med Surg | 2025 | https://conductscience.org/library/papers/40785853 | PubMed |
| 39795566 | Quantitative Physiologic MRI Combined with Feature Engineering for Developing Machine Learning-Based Prediction Models to Distinguish Glioblastomas from Single Brain Metastases. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/39795566 | PubMed |
| 39502470 | Distinction of pseudoprogression from true progression in glioblastomas using machine learning based on multiparametric magnetic resonance imaging and O6-methylguanine-methyltransferase promoter methylation status. | Neurooncol Adv | 2024 | https://conductscience.org/library/papers/39502470 | PubMed |
| 39429559 | The value of predicting neoadjuvant chemotherapy early efficacy in nasopharyngeal carcinoma based on amide proton transfer imaging and diffusion weighted imaging. | Quant Imaging Med Surg | 2024 | https://conductscience.org/library/papers/39429559 | PubMed |
| 38791921 | Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38791921 | PubMed |
| 38037172 | Differentiating primary central nervous system lymphoma from glioblastoma by time-dependent diffusion using oscillating gradient. | Cancer Imaging | 2023 | https://conductscience.org/library/papers/38037172 | PubMed |
| 37553578 | Differentiating brain metastasis from glioblastoma by time-dependent diffusion MRI. | Cancer Imaging | 2023 | https://conductscience.org/library/papers/37553578 | PubMed |
| 37492665 | Conventional and Advanced Imaging Techniques in Post-treatment Glioma Imaging. | Front Radiol | 2022 | https://conductscience.org/library/papers/37492665 | PubMed |
| 37016104 | Pretreatment synthetic magnetic resonance imaging predicts disease progression in nonmetastatic nasopharyngeal carcinoma after intensity modulation radiation therapy. | Insights Imaging | 2023 | https://conductscience.org/library/papers/37016104 | PubMed |
| 36698156 | The utility of texture analysis based on quantitative synthetic magnetic resonance imaging in nasopharyngeal carcinoma: a preliminary study. | BMC Med Imaging | 2023 | https://conductscience.org/library/papers/36698156 | PubMed |
| 36380750 | Value of DWI Combined with Magnetic Resonance Spectroscopy in the Differential Diagnosis between Recurrent Glioma and Radiation Injury: A Meta-Analysis. | Int J Clin Pract | 2022 | https://conductscience.org/library/papers/36380750 | PubMed |
| 36185045 | Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression. | Quant Imaging Med Surg | 2022 | https://conductscience.org/library/papers/36185045 | PubMed |
| 35954435 | Tumor Progression and Treatment-Related Changes: Radiological Diagnosis Challenges for the Evaluation of Post Treated Glioma. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35954435 | PubMed |
| 35907033 | Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [18F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma. | Eur J Nucl Med Mol Imaging | 2022 | https://conductscience.org/library/papers/35907033 | PubMed |
| 35185410 | Follow-Up of High-Grade Glial Tumor; Differentiation of Posttreatment Enhancement and Tumoral Enhancement by DCE-MR Perfusion. | Contrast Media Mol Imaging | 2022 | https://conductscience.org/library/papers/35185410 | PubMed |
| 35084518 | Response prediction of vestibular schwannoma after gamma-knife radiosurgery using pretreatment dynamic contrast-enhanced MRI: a prospective study. | Eur Radiol | 2022 | https://conductscience.org/library/papers/35084518 | PubMed |
| 34694565 | Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults. | J Neurooncol | 2022 | https://conductscience.org/library/papers/34694565 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23878286
GET https://conductscience.org/api/papers/v1/23878286/cited_by?page=2